Department of Pediatric, University of Medicine and Pharmacy "Victor Babes" Timisoara, Timișoara, Romania.
Pediatr Pulmonol. 2022 Feb;57(2):576-582. doi: 10.1002/ppul.25760. Epub 2021 Nov 23.
Pneumonia is the principal cause of death among children worldwide. Lung ultrasound (LUS) is a reliable tool for the diagnosis and assessment of community-acquired pneumonia in children. Furthermore, objective parameters, including the pneumonia LUS score, might be useful for pneumonia monitoring. Thus, our aim was to present a newly developed LUS score for pediatric pneumonia (PedPne) and evaluate its relationship with commonly assessed inflammatory markers.
Children referred to the Pediatric Pneumology Clinic between September 2017 and February 2018 with suspected pneumonia were screened for eligibility for inclusion in the study and informed consent was obtained. In addition to clinical assessment, LUS was performed during consultation, and inflammatory biomarkers, including C-reactive protein level, erythrocyte sedimentation rate (ESR), and leukocyte count, were measured in all inpatients. An LUS score for pneumonia and pleurisy in children (pediatric pneumonia lung ultrasound score [PedPne LUS]) was subsequently developed. Chest radiography (CXR) was also performed according to local guidelines for pneumonia diagnosis. Spearman's correlation test was used to evaluate the correlation between the PedPne score and inflammatory markers.
A total of 217 patients were screened, of which 64 patients diagnosed with consolidated pneumonia were included in this study. The median PedPne LUS score of the included patients was 8.02, which was consistent with the consolidations detected on LUS and confirmed by CXR. A very strong positive correlation was found between the LUS PedPne score and C-reactive protein and ESR, and a good correlation was found with the leukocyte count.
The LUS pneumonia score is a reliable parameter for the evaluation of pneumonia, and shows a strong correlation with inflammatory biomarkers. The PedPne LUS score is a potential noninvasive surrogate parameter of inflammation in pediatric pneumonia.
肺炎是全球儿童死亡的主要原因。肺部超声(LUS)是诊断和评估儿童社区获得性肺炎的可靠工具。此外,客观参数,包括肺炎 LUS 评分,可能有助于肺炎监测。因此,我们的目的是提出一种新的儿童肺炎肺部超声评分(PedPne),并评估其与常用炎症标志物的关系。
2017 年 9 月至 2018 年 2 月期间,我们筛选了儿科呼吸诊所就诊的疑似肺炎患儿,以评估其是否符合纳入研究的条件,并获得知情同意。除了临床评估外,我们在就诊期间还进行了 LUS 检查,并测量了所有住院患者的炎症生物标志物,包括 C 反应蛋白水平、红细胞沉降率(ESR)和白细胞计数。随后开发了一种儿童肺炎和胸膜炎的 LUS 评分(儿科肺炎肺部超声评分[PedPne LUS])。胸部 X 线摄影(CXR)也根据肺炎诊断的当地指南进行。采用 Spearman 相关检验评估 PedPne 评分与炎症标志物之间的相关性。
共筛选了 217 例患者,其中 64 例确诊为实变肺炎的患者纳入本研究。纳入患者的中位数 PedPne LUS 评分为 8.02,与 LUS 检测到的实变和 CXR 证实的实变一致。LUS PedPne 评分与 C 反应蛋白和 ESR 呈很强的正相关,与白细胞计数呈良好相关。
LUS 肺炎评分是评估肺炎的可靠参数,与炎症标志物具有很强的相关性。PedPne LUS 评分可能是儿童肺炎炎症的潜在非侵入性替代参数。